These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT. Byun JH, Kim TK, Lee CW, Lee JK, Kim AY, Kim PN, Ha HK, Lee MG. Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556 [Abstract] [Full Text] [Related]
5. Characterization of 1-to 2-cm liver nodules detected on hcc surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary? Jang HJ, Kim TK, Khalili K, Yazdi L, Menezes R, Park SH, Sherman M. AJR Am J Roentgenol; 2013 Aug; 201(2):314-21. PubMed ID: 23883211 [Abstract] [Full Text] [Related]
12. Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images. Kim M, Kang TW, Cha DI, Jang KM, Kim YK, Kim SH, Sinn DH, Kim K. Korean J Radiol; 2019 Feb; 20(2):236-245. PubMed ID: 30672163 [Abstract] [Full Text] [Related]
14. Value of precontrast and portal venous phases for evaluating atypical hepatocellular carcinoma mimicking arterioportal shunt. Song M, Park HJ, Lee ES, Ahn HS, Park SB. Eur J Radiol; 2021 Oct; 143():109933. PubMed ID: 34492626 [Abstract] [Full Text] [Related]
18. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT. Goshima S, Kanematsu M, Noda Y, Kawai N, Kawada H, Ono H, Bae KT. AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007 [Abstract] [Full Text] [Related]
19. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. Quaia E, De Paoli L, Angileri R, Pizzolato R, Cabibbo B, Cova MA. Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173 [Abstract] [Full Text] [Related]